eSpraye (Pulmonary fibrosis, Dry Powder) - Onyx Analyst
Dr. Adil Ali asks Dr. John Patton (CSO) and Dan Miller (Formulation Development Lead) all about eSpraye's drug pipeline.
Onyx Live
1 story
Make us preferred on Google1 story
Make us preferred on GoogleDr. Adil Ali asks Dr. John Patton (CSO) and Dan Miller (Formulation Development Lead) all about eSpraye's drug pipeline.
London · 15–19 November 2026
Explore Onyx’s independent guide to the events and make the most of your week in London.